keyword
https://read.qxmd.com/read/38607587/melatonin-and-oral-diseases-possible-therapeutic-roles-based-on-cellular-mechanisms
#21
REVIEW
Azam Hosseinzadeh, Ali Jamshidi Naeini, Mohammad Sheibani, Babak Gholamine, Russel J Reiter, Saeed Mehrzadi
Oral diseases, including periodontal disorders, oral cancer, periodontitis, and mucositis are the major challenges for both patients and healthcare providers. These conditions often involve inflammation, oxidative stress, and impaired cellular processes, leading to symptoms ranging from discomfort to severe debilitation. Conventional treatments for such oral diseases exhibit constraints, prompting the investigation of innovative therapeutic approaches. Considering the anti-inflammatory, anti-oxidant, and anti-cancer effects of melatonin, this study was carried out to investigate the potential protective effects of melatonin in mitigating the severity of oral diseases...
April 12, 2024: Pharmacological Reports: PR
https://read.qxmd.com/read/38607050/spotlight-on-new-hallmarks-of-drug-resistance-towards-personalized-care-for-epithelial-ovarian-cancer
#22
REVIEW
Simona Frezzini, Sara Lonardi
Epithelial ovarian cancer (EOC) is the deadliest gynecological malignancy worldwide. Despite the latest advances, a major clinical issue in EOC is the disappointing prognosis related to chemoresistance in almost one-third of cases. Drug resistance relies on heterogeneous cancer stem cells (CSCs), endowed with tumor-initiating potential, leading to relapse. No biomarkers of chemoresistance have been validated yet. Recently, major signaling pathways, micro ribonucleic acids (miRNAs), and circulating tumor cells (CTCs) have been advocated as putative biomarkers and potential therapeutic targets for drug resistance...
March 31, 2024: Cells
https://read.qxmd.com/read/38606999/phenotypic-heterogeneity-of-cancer-associated-fibroblasts-in-cervical-cancer-progression-fap-as-a-central-activation-marker
#23
JOURNAL ARTICLE
Lesly Jazmin Bueno-Urquiza, Marisol Godínez-Rubí, Julio César Villegas-Pineda, Alejandra Natali Vega-Magaña, Luis Felipe Jave-Suárez, Ana Graciela Puebla-Mora, Gloria Estefanía Aguirre-Sandoval, María Guadalupe Martínez-Silva, Adrián Ramírez-de-Arellano, Ana Laura Pereira-Suárez
Cervical cancer (CC) is the fourth leading cancer among women and is one of the principal gynecological malignancies. In the tumor microenvironment, cancer-associated fibroblasts (CAFs) play a crucial role during malignant progression, exhibiting a variety of heterogeneous phenotypes. CAFs express phenotypic markers like fibroblast activation protein (FAP), vimentin, S100A4, α-smooth muscle actin (αSMA), and functional markers such as MMP9. This study aimed to evaluate the protein expression of vimentin, S100A4, αSMA, FAP, and MMP9 in mesenchymal stem cells (MSC)-CAF cells, as well as in cervical cancer samples...
March 22, 2024: Cells
https://read.qxmd.com/read/38605972/advancing-diabetes-treatment-the-role-of-mesenchymal-stem-cells-in-islet-transplantation
#24
REVIEW
Lisha Mou, Tony Bowei Wang, Xinyu Wang, Zuhui Pu
Diabetes mellitus, a prevalent global health challenge, significantly impacts societal and economic well-being. Islet transplantation is increasingly recognized as a viable treatment for type 1 diabetes that aims to restore endogenous insulin production and mitigate complications associated with exogenous insulin dependence. We review the role of mesenchymal stem cells (MSCs) in enhancing the efficacy of islet transplantation. MSCs, characterized by their immunomodulatory properties and differentiation potential, are increasingly seen as valuable in enhancing islet graft survival, reducing immune-mediated rejection, and supporting angiogenesis and tissue repair...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38605399/the-implications-of-single-cell-rna-seq-analysis-in-prostate-cancer-unraveling-tumor-heterogeneity-therapeutic-implications-and-pathways-towards-personalized-therapy
#25
REVIEW
De-Chao Feng, Wei-Zhen Zhu, Jie Wang, Deng-Xiong Li, Xu Shi, Qiao Xiong, Jia You, Ping Han, Shi Qiu, Qiang Wei, Lu Yang
In recent years, advancements in single-cell and spatial transcriptomics, which are highly regarded developments in the current era, particularly the emerging integration of single-cell and spatiotemporal transcriptomics, have enabled a detailed molecular comprehension of the complex regulation of cell fate. The insights obtained from these methodologies are anticipated to significantly contribute to the development of personalized medicine. Currently, single-cell technology is less frequently utilized for prostate cancer compared with other types of tumors...
April 11, 2024: Military Medical Research
https://read.qxmd.com/read/38604170/single-cell-senescence-identification-reveals-senescence-heterogeneity-trajectory-and-modulators
#26
JOURNAL ARTICLE
Wanyu Tao, Zhengqing Yu, Jing-Dong J Han
Cellular senescence underlies many aging-related pathologies, but its heterogeneity poses challenges for studying and targeting senescent cells. We present here a machine learning program senescent cell identification (SenCID), which accurately identifies senescent cells in both bulk and single-cell transcriptome. Trained on 602 samples from 52 senescence transcriptome datasets spanning 30 cell types, SenCID identifies six major senescence identities (SIDs). Different SIDs exhibit different senescence baselines, stemness, gene functions, and responses to senolytics...
April 8, 2024: Cell Metabolism
https://read.qxmd.com/read/38602594/cancer-associated-fibroblasts-a-versatile-mediator-in-tumor-progression-metastasis-and-targeted-therapy
#27
REVIEW
Tianchen Guo, Junfen Xu
Tumor microenvironment (TME) has been demonstrated to play a significant role in tumor initiation, progression, and metastasis. Cancer-associated fibroblasts (CAFs) are the major component of TME and exhibit heterogeneous properties in their communication with tumor cells. This heterogeneity of CAFs can be attributed to various origins, including quiescent fibroblasts, mesenchymal stem cells (MSCs), adipocytes, pericytes, endothelial cells, and mesothelial cells. Moreover, single-cell RNA sequencing has identified diverse phenotypes of CAFs, with myofibroblastic CAFs (myCAFs) and inflammatory CAFs (iCAFs) being the most acknowledged, alongside newly discovered subtypes like antigen-presenting CAFs (apCAFs)...
April 11, 2024: Cancer Metastasis Reviews
https://read.qxmd.com/read/38601972/car-tcr-t-cells-co-expressing-cd33-car-and-dnpm1-tcr-as-superior-dual-targeting-approach-for-aml-treatment
#28
JOURNAL ARTICLE
Karin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, Vera Herbel, Nora Winter, Niels Werchau, Svetlana Khorkova, Christian Wöhle, Nojan Jelveh, Kevin Bisdorf, Boris Engels, Thomas Schaser, Kathleen Anders, Annette Künkele, Dominik Lock
Acute myeloid leukemia (AML), a fast-progressing hematological malignancy affecting myeloid cells, is typically treated with chemotherapy or hematopoietic stem cell transplantation. However, approximately half of the patients face relapses and 5-year survival rates are poor. With the goal to facilitate dual-specificity, boosting anti-tumor activity, and minimizing the risk for antigen escape, this study focused on combining chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies. CAR'TCR-T cells, co-expressing a CD33-CAR and a transgenic dNPM1-TCR, revealed increased and prolonged anti-tumor activity in vitro , particularly in case of low target antigen expression...
June 20, 2024: Mol Ther Oncol
https://read.qxmd.com/read/38601156/targeting-cd73-with-flavonoids-inhibits-cancer-stem-cells-and-increases-lymphocyte-infiltration-in-a-triple-negative-breast-cancer-mouse-model
#29
JOURNAL ARTICLE
Karan Mediratta, Sara El-Sahli, Marie Marotel, Muhammad Z Awan, Melanie Kirkby, Ammar Salkini, Reem Kurdieh, Salman Abdisalam, Amit Shrestha, Chiara Di Censo, Andrew Sulaiman, Sarah McGarry, Jessie R Lavoie, Zhen Liu, Seung-Hwan Lee, Xuguang Li, Giuseppe Sciumè, Vanessa M D'Costa, Michele Ardolino, Lisheng Wang
INTRODUCTION: Chemotherapy remains the mainstay treatment for triple-negative breast cancer (TNBC) due to the lack of specific targets. Given a modest response of immune checkpoint inhibitors in TNBC patients, improving immunotherapy is an urgent and crucial task in this field. CD73 has emerged as a novel immunotherapeutic target, given its elevated expression on tumor, stromal, and specific immune cells, and its established role in inhibiting anti-cancer immunity. CD73-generated adenosine suppresses immunity by attenuating tumor-infiltrating T- and NK-cell activation, while amplifying regulatory T cell activation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38600165/nrf2-activation-by-cysteine-as-a-survival-mechanism-for-triple-negative-breast-cancer-cells
#30
JOURNAL ARTICLE
Laura Bottoni, Alberto Minetti, Giulia Realini, Elena Pio, Daniela Giustarini, Ranieri Rossi, Chiara Rocchio, Lorenzo Franci, Laura Salvini, Orazio Catona, Romina D'Aurizio, Mahdi Rasa, Emanuele Giurisato, Francesco Neri, Maurizio Orlandini, Mario Chiariello, Federico Galvagni
Triple-negative breast cancer (TNBC) is a very aggressive and heterogeneous group of tumors. In order to develop effective therapeutic strategies, it is therefore essential to identify the subtype-specific molecular mechanisms underlying disease progression and resistance to chemotherapy. TNBC cells are highly dependent on exogenous cystine, provided by overexpression of the cystine/glutamate antiporter SLC7A11/xCT, to fuel glutathione synthesis and promote an oxidative stress response consistent with their high metabolic demands...
April 10, 2024: Oncogene
https://read.qxmd.com/read/38600092/sprouty-genes-regulate-activated-fibroblasts-in-mammary-epithelial-development-and-breast-cancer
#31
JOURNAL ARTICLE
Jiyong Li, Rongze Ma, Xuebing Wang, Yunzhe Lu, Jing Chen, Deyi Feng, Jiecan Zhou, Kun Xia, Ophir Klein, Hao Xie, Pengfei Lu
Stromal fibroblasts are a major stem cell niche component essential for organ formation and cancer development. Fibroblast heterogeneity, as revealed by recent advances in single-cell techniques, has raised important questions about the origin, differentiation, and function of fibroblast subtypes. In this study, we show in mammary stromal fibroblasts that loss of the receptor tyrosine kinase (RTK) negative feedback regulators encoded by Spry1, Spry2, and Spry4 causes upregulation of signaling in multiple RTK pathways and increased extracellular matrix remodeling, resulting in accelerated epithelial branching...
April 10, 2024: Cell Death & Disease
https://read.qxmd.com/read/38599194/considering-the-cellular-landscape-in-marrow-stimulation-techniques-for-cartilage-repair
#32
REVIEW
Maddie Hasson, Lorenzo M Fernandes, Hanna Solomon, Tristan Pepper, Nicholas L Huffman, Saitheja A Pucha, Jason T Bariteau, Jarred M Kaiser, Jay M Patel
BACKGROUND: Marrow stimulation is a common reparative approach to treat injuries to cartilage and other soft tissues (e.g., rotator cuff). It involves the recruitment of bone marrow elements and mesenchymal stem cells (MSCs) into the defect, theoretically initiating a regenerative process. However, the resulting repair tissue is often weak and susceptible to deterioration with time. The populations of cells at the marrow stimulation site (beyond MSCs), and their contribution to inflammation, vascularity, and fibrosis, may play a role in quality of the repair tissue...
April 10, 2024: Cells, Tissues, Organs
https://read.qxmd.com/read/38598841/variation-in-mesenchymal-kitl-scf-and-igf1-expression-at-middle-age-underlies-steady-state-hematopoietic-stem-cell-aging
#33
JOURNAL ARTICLE
Kira A Young, Maria A Telpoukhovskaia, Johanna Hofmann, Jayna J Mistry, Konstantinos Kokkaliaris, Jennifer J Trowbridge
Intrinsic molecular programs and extrinsic factors including pro-inflammatory molecules are understood to regulate hematopoietic aging. This is based on foundational studies using genetic perturbation to evaluate causality. However, individual organisms exhibit natural variation in hematopoietic aging phenotypes and the molecular basis of this heterogeneity is poorly understood. Here, we generated individual single cell transcriptomic profiles of hematopoietic and non-hematopoietic cell types in five young adult and nine middle-aged C57BL/6J female mice, providing a web-accessible transcriptomic resource for the field...
April 10, 2024: Blood
https://read.qxmd.com/read/38596189/does-progress-in-microfracture-techniques-necessarily-translate-into-clinical-effectiveness
#34
JOURNAL ARTICLE
Sathish Muthu, Vibhu Krishnan Viswanathan, Manoharan Sakthivel, Mohammed Thabrez
BACKGROUND: Multitudinous advancements have been made to the traditional microfracture (MFx) technique, which have involved delivery of various acellular 2nd generation MFx and cellular MFx-III components to the area of cartilage defect. The relative benefits and pitfalls of these diverse modifications of MFx technique are still not widely understood. AIM: To comparatively analyze the functional, radiological, and histological outcomes, and complications of various generations of MFx available for the treatment of cartilage defects...
March 18, 2024: World Journal of Orthopedics
https://read.qxmd.com/read/38594444/ifi35-regulates-non-canonical-nf-%C3%AE%C2%BAb-signaling-to-maintain-glioblastoma-stem-cells-and-recruit-tumor-associated-macrophages
#35
JOURNAL ARTICLE
Daqi Li, Xiefeng Wang, Kexin Chen, Danyang Shan, Gaoyuan Cui, Wei Yuan, Qiankun Lin, Ryan C Gimple, Deobrat Dixit, Chenfei Lu, Danling Gu, Hao You, Jiancheng Gao, Yangqing Li, Tao Kang, Junlei Yang, Hang Yu, Kefan Song, Zhumei Shi, Xiao Fan, Qiulian Wu, Wei Gao, Zhe Zhu, Jianghong Man, Qianghu Wang, Fan Lin, Weiwei Tao, Stephen C Mack, Yun Chen, Junxia Zhang, Chaojun Li, Nu Zhang, Yongping You, Xu Qian, Kailin Yang, Jeremy N Rich, Qian Zhang, Xiuxing Wang
Glioblastoma (GBM) is the most aggressive malignant primary brain tumor characterized by a highly heterogeneous and immunosuppressive tumor microenvironment (TME). The symbiotic interactions between glioblastoma stem cells (GSCs) and tumor-associated macrophages (TAM) in the TME are critical for tumor progression. Here, we identified that IFI35, a transcriptional regulatory factor, plays both cell-intrinsic and cell-extrinsic roles in maintaining GSCs and the immunosuppressive TME. IFI35 induced non-canonical NF-kB signaling through proteasomal processing of p105 to the DNA-binding transcription factor p50, which heterodimerizes with RELB (RELB/p50), and activated cell chemotaxis in a cell-autonomous manner...
April 9, 2024: Cell Death and Differentiation
https://read.qxmd.com/read/38592510/recent-developments-in-targeting-breast-cancer-stem-cells-bcscs-a-descriptive-review-of-therapeutic-strategies-and-emerging-therapies
#36
REVIEW
Khubaib Ali, Muhammad Nabeel, Fatima Mohsin, Mehwish Iqtedar, Muhammad Islam, Muhammad Fawad Rasool, Furqan K Hashmi, Syed Ahmed Hussain, Hamid Saeed
Despite recent advancements in the diagnosis and treatment of breast cancer (BC), patient outcomes in terms of survival, recurrence, and disease progression remain suboptimal. A significant factor contributing to these challenges is the cellular heterogeneity within BC, particularly the presence of breast cancer stem cells (BCSCs). These cells are thought to serve as the clonogenic nexus for new tumor growth, owing to their hierarchical organization within the tumor. This descriptive review focuses on the evolving strategies to target BCSCs, which have become a pivotal aspect of therapeutic development...
April 9, 2024: Medical Oncology
https://read.qxmd.com/read/38589411/single-cell-multiomics-reveals-the-interplay-of-clonal-evolution-and-cellular-plasticity-in-hepatoblastoma
#37
JOURNAL ARTICLE
Amélie Roehrig, Theo Z Hirsch, Aurore Pire, Guillaume Morcrette, Barkha Gupta, Charles Marcaillou, Sandrine Imbeaud, Christophe Chardot, Emmanuel Gonzales, Emmanuel Jacquemin, Masahiro Sekiguchi, Junko Takita, Genta Nagae, Eiso Hiyama, Florent Guérin, Monique Fabre, Isabelle Aerts, Sophie Taque, Véronique Laithier, Sophie Branchereau, Catherine Guettier, Laurence Brugières, Brice Fresneau, Jessica Zucman-Rossi, Eric Letouzé
Hepatoblastomas (HB) display heterogeneous cellular phenotypes that influence the clinical outcome, but the underlying mechanisms are poorly understood. Here, we use a single-cell multiomic strategy to unravel the molecular determinants of this plasticity. We identify a continuum of HB cell states between hepatocytic (scH), liver progenitor (scLP) and mesenchymal (scM) differentiation poles, with an intermediate scH/LP population bordering scLP and scH areas in spatial transcriptomics. Chromatin accessibility landscapes reveal the gene regulatory networks of each differentiation pole, and the sequence of transcription factor activations underlying cell state transitions...
April 8, 2024: Nature Communications
https://read.qxmd.com/read/38588769/cost-effective-and-scalable-clonal-hematopoiesis-assay-provides-insight-into-clonal-dynamics
#38
JOURNAL ARTICLE
Taralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, Alexander J Silver, J Brett Heimlich, Hannah Poisner, Henry Robert Condon, Jessica Ulloa, Andrew L Sochacki, Travis P Spaulding, Ashwin Kishtagari, Cosmin A Bejan, Yaomin Xu, Michael R Savona, Angela Jones, Alexander Bick
Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related phenomenon that occurs when hematopoietic stem cells acquire mutations in a select set of genes commonly mutated in myeloid neoplasia which then expand clonally. Current sequencing assays to detect CHIP mutations are not optimized for the detection of these variants and can be cost-prohibitive when applied to large cohorts or serial sequencing. In this study, an affordable (∼$8 per sample), accurate, and scalable sequencing assay for CHIP is introduced and validated...
April 6, 2024: Journal of Molecular Diagnostics: JMD
https://read.qxmd.com/read/38584674/stem-cells-derived-exosomes-as-cardiac-regenerative-agents
#39
REVIEW
Raheleh Farahzadi, Ezzatollah Fathi, Behnaz Valipour, Saba Ghaffary
Heart failure is a root cause of morbidity and mortality worldwide. Due to the limited regenerative capacity of the heart following myocardial injury, stem cell-based therapies have been considered a hopeful approach for improving cardiac regeneration. In recent years, different kinds of cell products have been investigated regarding their potential to treat patients with heart failure. Despite special attention to cell therapy and its products, therapeutic efficacy has been disappointing, and clinical application is not affordable...
June 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38584256/identification-of-fatty-acids-synthesis-and-metabolism-related-gene-signature-and-prediction-of-prognostic-model-in-hepatocellular-carcinoma
#40
JOURNAL ARTICLE
Ai Zhengdong, Xing Xiaoying, Fu Shuhui, Liang Rui, Tang Zehui, Song Guanbin, Yang Li, Tang Xi, Liu Wanqian
BACKGROUND: Fatty acids synthesis and metabolism (FASM)-driven lipid mobilization is essential for energy production during nutrient shortages. However, the molecular characteristics, physiological function and clinical prognosis value of FASM-associated gene signatures in hepatocellular carcinoma (HCC) remain elusive. METHODS: The Gene Expression Omnibus database (GEO), the Cancer Genome Atlas (TCGA), and International Cancer Genome Consortium (ICGC) database were utilized to acquire transcriptome data and clinical information of HCC patients...
April 7, 2024: Cancer Cell International
keyword
keyword
158526
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.